MOTIZA 50MG TABLET
₹78.88*
MRP ₹87.64
10% off
₹74.64*
MRP ₹87.64
15% CB
₹13 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
MOTIZA 50MG TABLET belongs to a class of drugs called 'gastroprokinetic agent, gastrokinetic agent or propulsive' primarily used in treating the disorders associated with reduced gastrointestinal motility. Besides this, MOTIZA 50MG TABLET also treats gastrointestinal disorders like dyspepsia (indigestion), bloating (feeling of stomach tightness due to gas), upper abdominal pain, anorexia (eating disorder), heartburn, nausea and vomiting. In the normal digestion condition, the food is moved through the entire digestive tract (food pipe, stomach, small intestine and large intestine) by a rhythmic contraction, i.e. peristalsis movement. This regular movement of the digestive tract is called 'gastric motility.' When an individual suffers from a digestive motility problem, these digestive tract contractions do not work properly, leading to various gastrointestinal issues.
MOTIZA 50MG TABLET contains 'Itopride Hydrochloride' that increases the level of acetylcholine concentration, increasing the Gastrointestinal peristalsis movement, thereby accelerating gastric emptying time and easing the movement of food through the entire gastrointestinal tract. MOTIZA 50MG TABLET also stops the sensation of vomiting/nausea by blocking the D2 receptors located in the chemoreceptor trigger zone - CTZ of the brain responsible for inducing vomiting.
Your doctor will advise you on how often you take your pills based on your medical condition. You may sometimes experience diarrhoea, stomach pain, headache, tremor (involuntary movement) and drowsiness. Most of these side effects of MOTIZA 50MG TABLET do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are known to be allergic to MOTIZA 50MG TABLET or any other medicines, please tell your doctor. MOTIZA 50MG TABLET is not recommended for children below 16 years of age. If pregnant or breastfeeding, please inform your doctor before taking the MOTIZA 50MG TABLET. If you have Parkinson's disease or internal bleeding of the stomach and intestine, please consult a doctor before taking MOTIZA 50MG TABLET. If you notice dark, coffee-coloured stools or blood in stools, contact your doctor immediately, as these might be signs of bleeding in the stomach.
MOTIZA 50MG TABLET is a gastroprokinetic agent (enhances the movement of food from the mouth through the stomach and intestines) that is used for treating gastrointestinal symptoms such as heartburn, vomiting, nausea, bloating (stomach feels swollen due to build-up of gas), non-ulcer dyspepsia (indigestion), discomfort or pain in the abdomen. MOTIZA 50MG TABLET prevents heartburn by enhancing the movement of food through the stomach and intestines. Also, MOTIZA 50MG TABLET acts on the brain's chemoreceptor trigger zone (the area that triggers vomiting) and prevents vomiting.
Patients with reduced kidney or liver functions should be monitored carefully, and the dose should be adjusted accordingly. MOTIZA 50MG TABLET may be excreted in breast milk. Therefore, breastfeeding or pregnant women are advised to consult a doctor before taking MOTIZA 50MG TABLET. If you notice dark, coffee-coloured stools or blood in stools, contact your doctor immediately, as these might be signs of bleeding in the stomach. Do not take MOTIZA 50MG TABLET if you have increased gastrointestinal haemorrhage (internal bleeding of intestine and stomach), gastrointestinal motility (movement of food from the mouth through stomach and intestine), mechanical perforation or obstruction, as it may worsen the condition.
Drug-Drug Interactions: MOTIZA 50MG TABLET may interact with anticholinergic agents (dicyclomine, trihexyphenidyl, ipratropium, belladonna alkaloids, benztropine mesylate, flavoxate, atropine, scopolamine and hyoscyamine).
Drug-Food Interactions: MOTIZA 50MG TABLET may interact with grapefruit juice. Therefore, avoid consuming grapefruit juice with MOTIZA 50MG TABLET as it may increase the risk of adverse effects.
Drug-Disease Interactions: Do not use MOTIZA 50MG TABLET in patients with Parkinson’s disease, gastrointestinal bleeding, Lapp lactase deficiency, galactose intolerance or glucose-galactose malabsorption.
Gastric motility disorder: In the normal digestion condition, the food is moved through the entire digestive tract (food pipe, stomach, small intestine and large intestine) by a rhythmic contraction, i.e. peristalsis movement. This regular movement of the digestive tract is called 'gastric motility.' When an individual suffers from a digestive motility problem, these digestive tract contractions do not work properly, leading to various gastrointestinal issues.
Country of origin
Manufacturer/Marketer address
Customers Also Bought
Alcohol
Caution
The interaction of alcohol with MOTIZA 50MG TABLET is unknown. Please consult a doctor before consuming alcohol while using MOTIZA 50MG TABLET.
Pregnancy
Caution
Let your doctor know if you are a nursing mother before taking MOTIZA 50MG TABLET; your doctor will decide whether MOTIZA 50MG TABLET can be taken by breastfeeding mothers or not.
Breast Feeding
Caution
Let your doctor know if you are a nursing mother before taking MOTIZA 50MG TABLET; your doctor will decide whether MOTIZA 50MG TABLET can be taken by breastfeeding mothers or not.
Driving
Caution
MOTIZA 50MG TABLET may cause dizziness or reduce alertness in some people. So, drive only if you are alert after taking MOTIZA 50MG TABLET.
Liver
Caution
If you have had a history or evidence of any liver-related diseases, please consult the doctor before taking MOTIZA 50MG TABLET. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Kidney
Caution
If you have had a history or evidence of any kidney-related diseases, please consult the doctor before taking MOTIZA 50MG TABLET. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Children
Unsafe
MOTIZA 50MG TABLET is not recommended for children below 16 years as the safety and effectiveness were not established.
We provide you with authentic, trustworthy and relevant information